Bank of America reiterated its Underperform rating on Molina Healthcare MOH but raised its price target from $22 to $23.
Bank of America noted, "Overall, we are raising our 2013-2014 EPS estimates modestly to $1.40 (from $1.35) and $1.95 (from $1.90), respectively, since we already assumed Texas improvement in the out years. Our Underperform rating is based on a view that while MOH is well positioned for revenue growth, sustainable margins may just creep back to ~1.50% over time more inline with the company's 1.49% average since 2005."
Molina Healthcare closed at $22.73 on Tuesday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in